Nammi Therapeutics

Los Angeles, United States

Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.

$1.0M raised

Aug 2024

Series B

Biotechnology Service Industry Therapeutics

Top Investors

Myeloma Investment Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nammi Therapeutics

How much funding has Nammi Therapeutics raised?

Nammi Therapeutics has raised $1.0M in total funding. The most recent round was Series B. The last funding was announced in August 2024.

Who are Nammi Therapeutics's investors?

Nammi Therapeutics's investors include Myeloma Investment Fund.

Where is Nammi Therapeutics headquartered?

Nammi Therapeutics is headquartered in Los Angeles, United States.

What does Nammi Therapeutics do?

Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.

What stage is Nammi Therapeutics at?

Nammi Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 6, 2024.

MLA

"Nammi Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/nammi-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2024). Nammi Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/nammi-therapeutics

Wikipedia (cite web)

{{cite web |title=Nammi Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nammi-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 6, 2024.

Similar Companies in Biotechnology